- Home
- FLNC vs PSNL Comparison
FLNC vs PSNL Comparison
Compare FLNC & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNC
- PSNL
- Stock Information
- Founded
- FLNC 2018
- PSNL 2011
- Country
- FLNC United States
- PSNL United States
- Employees
- FLNC N/A
- PSNL N/A
- Industry
- FLNC Industrial Machinery/Components
- PSNL Medical Specialities
- Sector
- FLNC Miscellaneous
- PSNL Health Care
- Exchange
- FLNC Nasdaq
- PSNL Nasdaq
- Market Cap
- FLNC 533.2M
- PSNL 460.7M
- IPO Year
- FLNC 2021
- PSNL 2019
- Fundamental
- Price
- FLNC $4.52
- PSNL $4.98
- Analyst Decision
- FLNC Buy
- PSNL Strong Buy
- Analyst Count
- FLNC 19
- PSNL 5
- Target Price
- FLNC $12.37
- PSNL $8.00
- AVG Volume (30 Days)
- FLNC 4.7M
- PSNL 753.6K
- Earning Date
- FLNC 05-07-2025
- PSNL 05-06-2025
- Dividend Yield
- FLNC N/A
- PSNL N/A
- EPS Growth
- FLNC N/A
- PSNL N/A
- EPS
- FLNC N/A
- PSNL N/A
- Revenue
- FLNC $2,329,871,000.00
- PSNL $85,694,000.00
- Revenue This Year
- FLNC $20.84
- PSNL N/A
- Revenue Next Year
- FLNC $21.68
- PSNL $27.82
- P/E Ratio
- FLNC N/A
- PSNL N/A
- Revenue Growth
- FLNC 6.08
- PSNL 15.57
- 52 Week Low
- FLNC $3.46
- PSNL $1.14
- 52 Week High
- FLNC $26.12
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- FLNC 55.02
- PSNL 69.55
- Support Level
- FLNC $3.93
- PSNL $3.98
- Resistance Level
- FLNC $4.90
- PSNL $5.61
- Average True Range (ATR)
- FLNC 0.31
- PSNL 0.35
- MACD
- FLNC 0.17
- PSNL 0.18
- Stochastic Oscillator
- FLNC 83.96
- PSNL 75.10
About FLNC Fluence Energy Inc.
Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.